Skip to main content

Table 3 Clinical management summary of 13 Ebola virus disease patients treated outside West Africa

From: Ebola virus disease and critical illness

Reference

[76]

[76]

[42]

[28, 79, 137]

[78, 79, 82]

[81, 82]

[38]

[25, 77]

[28, 99]

[81]

[81]

[82]

[37]

Demographics

 Gender

M

F

M

M

M

M

M

F

M

F

F

M

M

 Age (years)

33

59

36

51

43

42

38

44

33

26

29

44

43

 Country of infection

Liberia

Liberia

Sierra Leone

Liberia

Sierra Leone

Liberia

Sierra Leone

Spain

Liberia

USA

USA

Sierra Leone

Sierra Leone

 Country providing care

USA

USA

Germany

USA

USA

USA

Germany

Spain

USA

USA

USA

USA

Switzerland

Hospital admission

 Admission date

2 Aug 2014

5 Aug 2014

27 Aug 2014

5 Sep 2014

9 Sep 2014

30 Sep 2014

3 Oct 2014

6 Oct 2014

6 Oct 2014

11 Oct 2014

14 Oct 2014

15 Nov 2014

21 Nov 2014

 Days from diagnosis to evacuation

7

10

4

7

2

N/A

5

0

5

N/A

N/A

6

4

 Hospital LOS

19

14

30

20

41

8

47

30

16

13

14

3

15

 Vital status

Survived

Survived

Survived

Survived

Survived

Died

Survived

Survived

Survived

Survived

Survived

Died

Survived

Critical care therapies

 Central line

N

N

Y

Y

Y

Y

Y

N

Y

Y

N

Y

Y

 Vasopressors

N

N

N

N

Y

Y

Y

N

N

N

N

Y

N

 Oxygen

Y

Y

Y

Y

Y

Y

Y

Y

N

N

N

Y

N

 NIV (d, days)

N

N

Y (8d)

N

N

N

Y (1d)

N

N

N

N

N

N

 MV (d, days)

N

N

N

N

Y (17d)

Y (5d)

Y (13d)

N

N

N

N

Y (3d)

N

 CRRT (d, days)

N

N

N

N

Y (24d)

Y (5d)

Y (18d)

N

N

N

N

Y (3d)

N

 IHD (d, days)

N

N

N

N

N

N

Y (10d)

N

N

N

N

N

N

Experimental therapies

 Convalescent plasma

Y

N

N

Y

Y

N

N

Y

Y

Y

Y

Y

N

 ZMapp/ZMab

Y

Y

N

N

N

N

N

Y

N

Y

N

Y

Y

 Brincidofovir

N

N

N

N

N

Y

N

N

Y

Y

Y

N

N

 Favipiravir

N

N

Y

N

N

N

Y

Y

N

N

N

N

Y

TKM

N

N

Y

Y

Y

N

N

N

N

Y

N

N

N

 Other

N/A

N/A

N/A

N/A

N/A

N/A

Amiodarone, FX06

N/A

N/A

N/A

N/A

N/A

N/A

  1. CRRT continuous renal replacement therapy; F female, IHD intermittent hemodialysis, LOS length of stay, M male, MV invasive mechanical ventilation, N/A not available, NIV non-invasive ventilation, TKM TKM-Ebola, small interfering ribonucleic acids (siRNA) produced by Tekmira